Dr. Anthony Colletta is a non-exec Director of Eykona Technologies.

Dr. Colletta was most recently CEO and head of the healthcare equity and PIPES funds at Satellite Asset Management UK LLP. Previously he was Managing Director responsible for global healthcare equity research at Dresdner Kleinwort Benson in London and, from 1995 to 2000 was head of healthcare equity research and investment banking at ABN AMRO as well as leading the healthcare group at ABN AMRO private equity. From 1984 to 1992 Anthony was a scientist working in endocrine oncology at King’s College Hospital in London, at The National Cancer Institute in Bethesda, USA and the Department of Clinical Biochemistry at Addenbrookes Hospital, Cambridge University. He was a group head at the Institute of Cancer Research and Royal Marsden Hospital in London from 1992 to 1995 and remains a lifetime honorary research fellow there. From 1997 to 2001 Anthony was a non-executive director of Neutec Pharma PLC.  He was awarded a Doctorate from King’s College Hospital School of Medicine and Dentistry.